Mixmag: Researchers study music app to treat brain fog
After going through medical treatment like chemotherapy or recovering from a COVID-19 infection, some patients report brain fog, characterized by issues with thinking, focusing or remembering.
University of Cincinnati researchers led by Soma Sengupta, MD, PhD, associate professor and Harold C. Schott Endowed Chair of Molecular Therapeutics in the Department of Neurology and a UC Health neuro-oncologist; and Claudia Rebola, PhD, associate dean for research, associate professor and director of the new Center for DAAP Research and Innovation (CDRI) on Health and Wellbeing in the College of Design, Architecture, Art, and Planning, are leading a pilot study examining music therapy's effect on brain fog through a mobile app.
British electronic dance music magazines Mixmag and DJ Mag recently featured the research in their technology sections, noting that study participants are placed into groups that either listen to or make music through the app for 15 minutes each day.
The app is "helping the rewiring and exercising areas of the brain that normally wouldn't do it," Sengupta said.
Featured photo at top of app in use courtesy of Claudia Rebola, PhD.
Related Stories
The subtle changes in hearing you should never ignore
July 24, 2026
It’s easy to dismiss changes in hearing as minor. But as The Washington Post recently reported, these symptoms could also signal a medical emergency that many people don’t recognize — known as sudden sensorineural hearing loss, a rapid decline in hearing that occurs suddenly or over a few days.
UC experts say proper produce washing is key defense against Cyclospora
July 24, 2026
Hamilton County Public Health reports confirmed cases of cyclosporiasis, as concerns persist. Cyclospora is a parasite that can cause a stomach illness lasting days — sometimes even weeks. University of Cincinnati medical experts say it is usually linked to contaminated water or food, often fresh produce.
What are the options for male birth control?
July 24, 2026
Despite major advances in contraception during the past several decades, responsibility for pregnancy prevention falls largely on women. As recently reported in Endocrinology Advisor, a new generation of male contraceptive candidates is advancing into early- and mid-stage clinical trials.